News | Page 96 | Englander Institute for Precision Medicine

EIPM Studies Outcomes in Cancer Patients with COVID-19

October 16, 2020

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19, a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian has found. The findings suggest that in the absence of other risk factors for poor COVID-19 outcomes, patients with cancer may be able to safely continue treatment during the...

New Study Examines Mysteries of COVID-19

October 12, 2020

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms? The multidisciplinary team will seek to identify underlying genetic and immune factors that contribute to these varying outcomes to help guide the development of precision prevention and treatment efforts.

The ...

EIPM October 2020 External Newsletter

October 6, 2020

The EIPM External Newsletter below is sent quarterly to people who sign-up on our website.

Dear Friends of the EIPM:

During these extraordinary times we have continued to create breakthroughs in basic research that will benefit patients with cancer, metabolic disease, neurologic impairments, and many more conditions. Our researchers have also worked collaboratively with investigators across the country and around the world to unlock the mysteries of Covid-19, and...